Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...
12h
News Medical on MSNAI approach reveals possible fusion of rare diseases in COVID-19 origins In A Landmark Dis...Despite extensive research, the origins of COVID-19 remain elusive. In a new study published in the KeAi journal Advances in Biomarker Sciences and Technology (ABST), an AI-driven approach was adopted ...
A study on bat genomes, involving Texas Tech University, discovered genetic adaptations that help bats resist viral ...
2d
News Medical on MSNBat gene provides insight into fighting COVID-19 and other viral diseasesFive years removed from the COVID-19 outbreak, scientists around the world are still studying its effects and, more importantly, ways those effects can be mitigated in the future.
The same mechanisms involved in COVID-related cardiovascular events are responsible for COVID-related myocarditis.
A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...
6d
GlobalData on MSNThermo Fisher continues viral vector withdrawal; lays off 300 employeesThe cuts at two Massachusetts plants follow further site closures and layoffs across the company over the past few years.
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
COVID-19 vaccines used in Brazil are from three different technology platforms. Besides Pfizer's, which contains synthetic RNA from SARS-CoV-2, there are also the viral vector vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results